Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation.
about
Adenosylmethionine decarboxylase 1 (AMD1)-mediated mRNA processing and cell adhesion activated & inhibited transition mechanisms by different comparisons between chimpanzee and human left hemisphere.High EGFR_1 Inside-Out Activated Inflammation-Induced Motility through SLC2A1-CCNB2-HMMR-KIF11-NUSAP1-PRC1-UBE2C.Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analysesCDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancerEarly transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patientsCyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.Activated amelogenin Y-linked (AMELY) regulation and angiogenesis in human hepatocellular carcinoma by biocomputation.miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinomaThe effects of short-term high-fat feeding on exercise capacity: multi-tissue transcriptome changes by RNA sequencing analysis.Investigation of potential molecular biomarkers and small molecule drugs for hepatocellular carcinoma transformed from cirrhosis.CAMK1 phosphoinositide signal-mediated protein sorting and transport network in human hepatocellular carcinoma (HCC) by biocomputation.Inhibited PTHLH downstream leukocyte adhesion-mediated protein amino acid N-linked glycosylation coupling Notch and JAK-STAT cascade to iron-sulfur cluster assembly-induced aging network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection)PTHLH coupling upstream negative regulation of fatty acid biosynthesis and Wnt receptor signal to downstream peptidase activity-induced apoptosis network in human hepatocellular carcinoma by systems-theoretical analysis.E2F1 interactive with BRCA1 pathway induces HCC two different small molecule metabolism or cell cycle regulation via mitochondrion or CD4+T to cytosol.Low BIK outside-inside-out interactive inflammation immune-induced transcription-dependent apoptosis through FUT3-PMM2-SQSTM1-SFN-ZNF384.YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.Low glucose transporter SLC2A5-inhibited human normal adjacent lung adenocarcinoma cytoplasmic pro-B cell development mechanism network.Activated PTHLH coupling feedback phosphoinositide to G-protein receptor signal-induced cell adhesion network in human hepatocellular carcinoma by systems-theoretic analysis.
P2860
Q30009445-CC893390-EDF6-4609-BEB0-71A04A1DBC5EQ30651265-EDEA0D4F-7436-4AE8-8F7F-826ED31A4165Q33652971-3AE5AEDB-44EA-4C30-AB3B-8EA5CEDD868DQ34769837-470B19FD-1910-41A0-8462-AAC30F9B4DFEQ35853889-47E1A9DA-19C8-46C8-BB10-DE5B95A0A136Q35951544-45AF01B3-992B-44FD-9E2A-998283DF2BD0Q36170317-E8629CD2-B5C6-423E-9C3A-80E26859F159Q36621353-40EDCA44-9269-4253-8354-04873317784AQ36629563-F260A50A-6B88-4563-9FA0-28AF3C8CE7A6Q37623005-770FBDC1-BC1E-46E1-9284-5E301F2B6859Q38445536-036D205B-3144-4DDC-A693-636DD14C8316Q38476898-EBC9DCE2-FDDB-4038-B0A3-7C40F90642D0Q38495203-3EAD2966-3838-4F24-BBE0-812AF42400FAQ38496076-BDB6CD75-A66E-4324-8D7D-876BABCA2B77Q47562392-9C136C02-1EEC-475F-822E-04037DECFF2DQ47951691-CCCD867D-7036-450D-A57B-0C3FCB98B643Q48248996-927EDAA5-A15E-4367-AD3C-435A208D4FCFQ53010586-93410032-E135-4BA7-918E-C6C3CE2D22E0Q54482194-1EC30515-2A66-4A1D-AB79-C3B11EAD7F5F
P2860
Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cyclin-dependent kinase inhibi ...... arcinoma (HCC) transformation.
@en
type
label
Cyclin-dependent kinase inhibi ...... arcinoma (HCC) transformation.
@en
prefLabel
Cyclin-dependent kinase inhibi ...... arcinoma (HCC) transformation.
@en
P2093
P2860
P1433
P1476
Cyclin-dependent kinase inhibi ...... arcinoma (HCC) transformation.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2184.2011.00752.X
P577
2011-06-01T00:00:00Z